Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

about

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

Item

http://www.wikidata.org/entity/Q47606148

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@en

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@nl

type

Item

label

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@en

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@nl

prefLabel

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@en

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@nl

P1476

Phlpp inhibitors block pain and cartilage degradation associated with osteoarthritis.

@en

P2093

Dana L Begun

http://www.w3.org/2001/XMLSchema#string

Elizabeth W Bradley

http://www.w3.org/2001/XMLSchema#string

Jennifer J Westendorf

http://www.w3.org/2001/XMLSchema#string

Kirsty L Culley

http://www.w3.org/2001/XMLSchema#string

Lauren E Ta

http://www.w3.org/2001/XMLSchema#string

Lomeli Carpio Shull

http://www.w3.org/2001/XMLSchema#string

Marina Feigenson

http://www.w3.org/2001/XMLSchema#string

Mary B Goldring

http://www.w3.org/2001/XMLSchema#string

Miguel Otero

http://www.w3.org/2001/XMLSchema#string

Sanjeev Kakar

http://www.w3.org/2001/XMLSchema#string

P2860

Why patients visit their doctors: assessing the most prevalent conditions in a defined American population

Current research on pharmacologic and regenerative therapies for osteoarthritis

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis

PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth

Suppression of survival signalling pathways by the phosphatase PHLPP

Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data.

Discovery of small molecule inhibitors of the PH domain leucine-rich repeat protein phosphatase (PHLPP) by chemical and virtual screening.

American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.

Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output.

P31

scholarly article

P356

10.1002/JOR.23781

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29068480

http://www.w3.org/2001/XMLSchema#string

P921

osteoarthritis

P932

5985222

http://www.w3.org/2001/XMLSchema#string